http://chineseinput.net/에서 pinyin(병음)방식으로 중국어를 변환할 수 있습니다.
변환된 중국어를 복사하여 사용하시면 됩니다.
Denosumab for Treatment of a Recurrent Cervical Giant-Cell Tumor
Daisuke Kajiwara,Hiroto Kamoda,Tsukasa Yonemoto,Shintaro Iwata,Takeshi Ishii,Toshinori Tsukanishi,Seiji Ohtori,Masashi Yamazaki,Akihiko Okawa 대한척추외과학회 2016 Asian Spine Journal Vol.10 No.3
A 43-year-old male patient with C5 giant cell tumor (GCT) underwent tumor resection and anterior bone fusion of C4–C6. The tumor recurred locally 9 months after surgery with the patient complaining of neck and shoulder pain similar to his preoperative symptoms. Denosumab was administered and his pain disappeared after a two-month administration, with a sclerotic rim formation seen at the tumor site on computed tomography. He has been followed for 18 months with no evidence of tumor recurrence. Complete resection is generally recommended, but is not easy for many patients with cervical GCT because of the existence of neurovascular structures. Some patients suffer from recurrence and treatment becomes more difficult. As such, denosumab may be an efficacious option for treatment of recurrent GCT of the cervical spine, although long-term follow-up is required to monitor for presence or absence of recurrence.